Re: ADHESION BARRIERS (currently in clinical trials)

From: BETH (saralarou@AOL.COM)
Fri Mar 24 08:21:58 2000


At Fri, 4 Feb 2000, Helen Dynda wrote: >
>I have included the * press releases* websites for each of these
>pharmaceutical companies. This will enable you to follow the progress of
>the gel adhesion barriers - which are now in clinical trials in the United
>States - as they seek to be approved by the FDA.
>
>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
>
>** ALLIANCE PHARMACEUTICAL **
>
>1.) * July 1999 - FloGel (A Liquid/Gel Under Development for the Reduction
>of Postsurgical Adhesions) - About FloGel - Technology Overview - The FloGel
>Advantage - Glossary of Terms
>
>http://www.allp.com/FloGel/FG.HTM
>
>2.) * October 21, 1999 - Alliance Pharmaceutical Corp. Announces Flo Gel
>Reduced Post-Surgical Adhesions in Pilot Clinical Trial
>
>http://www.allp.com/press/press.exe?@91021
>
>3.) * PRESS RELEASES - for Alliance Pharmaceutical
>
>http://www.allp.com/press/press.exe?db=pressrel
>
>~~~~~~~~~~~~~~~~~~~~~~~~
>
>** ANIKA THERAPEUTICS **
>
>1.) * August 11, 1998 - Incert Shown to Reduce Postoperative Adhesion
>Formation - click the date shown.
>
>http://www.anikatherapeutics.com/newset.htm
>
>2.) * PRESS RELEASES - for Anika Therapeutics
>http://www.anikatherapeutics.com/newset.htm
>
>~~~~~~~~~~~~~~~~~~~~~~
>
>** GENZYME GENERAL **
>
>1.) * April 30, 1999 - Genzyme General Says Study is Largest to Document
>Complications Related to Adhesions.
>
>http://www.genzyme.com/ir/gzsp/press/19990430.html
>
>2.) * May 4, 1999 - New Data on Post-Surgical Adhesions and Small Bowel
>Obstruction Presented at Genzyme Symposium
>
>http://www.genzyme.com/ir/gzsp/press/19990504.html
>
>3.) * Completed Studies: Prevention of Postoperative Abdominal Adhesions by
>a Sodium Hyaluronate- Based Bioresorbable Membrane -- Abdominal
>Adhesiolysis: Inpatient Care and Expenditures in the United States in 1994.
>(You may need to type the entire URL on the address line of your computer.)
>
>http://www.genzyme.com/prodserv/surgical_products/seprafilm/clinical/study.h
>tm
>
>4.) * In Progress Research: A Prospective, Randomized, Multicenter,
>Controlled Evaluation of the Efficacy and Safety of Seprafilm Bioresorbable
>Membrane in the Reduction of the Incidence of Bowel Obstruction in General
>Surgery. (You may need to type the entire URL on the address line of your
>computer.)
>
>http://www.genzyme.com/prodserv/surgical_products/seprafilm/clinical/progres
>s.htm
>
>5.) * PRESS RELEASES - for Genzyme Surgical Products
>
>http://www.genzyme.com/ir/gzsp/press/welcome.htm
>
>~~~~~~~~~~~~~~
>
>** GLIATECH **
>
>1.) * ADCON Products - click each product for more information.
>
>http://www.gliatech.com/pages/products/index.html
>
>2.) * January 28, 1999 - Gliatech Announces Initiation of Pivotal ADCON-P
>Clinical Trial.
>
>http://www.gliatech.com/news/newsread.cfm?ID4
>
>3.) * July 20, 1999 - Gliatech Announces FDA Approval to Initiate Clinical
>Trials of ADCON-A.
>
>http://www.gliatech.com/news/newsread.cfm?ID2
>
>4.) * PRESS RELEASES - for Gliatech
>http://www.gliatech.com/news/news.cfm
>
>~~~~~~~~~~~~~~~~~~~~~~~~~
>
>** LIFECORE BIOMEDICAL **
>
>1.) * Intergel: an animation showing the surgical application of Intergel.
>
>http://www.lifecore.com/hy/hyaluron.htm
>
>2.) * March 8, 1999 - Lifecore Biomedical, Inc. announced today that it has
>completed the filing of its premarket approval (PMA) application for the
>Company's ferric hyaluronate product, Intergel Prevention Solution, with the
>submission to the FDA of the fifth and final module of that document last
>week.
>
>http://www.lifecore.com/press_release/press22.htm
>
>3.) * May 5, 1999 - Lifecore Anti-Adhesion Product PMA Accepted for Filing
>by FDA with Expedited Review Status.
>
>http://www.lifecore.com/press_release/press24.htm
>
>4.) * October 8, 1999 - Intergel Adhesion Prevention Solution PMA Review
>Scheduled for November 16, 1999 Advisory Panel Meeting
>
>http://www.lifecore.com/press_release/press27.htm
>
>5.) * October 22, 1999 - Lifecore Biomedical Announces Postponement of
>November 16 General and Plastic Surgery Devices Advisory Panel Meeting.
>
>http://www.lifecore.com/press_release/press29.htm
>
>6.) * PRESS RELEASES - for Lifecore Biomedical
>
>http://www.lifecore.com/press_release/current.htm
>
>~~~~~~~~~~~~~~~~~~~~~~~~~~
>
>** LIFE MEDICAL SCIENCES **
>
>1.) * Bioresorbable Polymer Technology - click "Products" for information
>about Life Medical Science's adhesion barriers: REPEL - REPEL-C - RESOLVE -
>RELIEVE
>
>http://www.lifemed.com/
>
>2.) * January 21, 1999 - Life Medical Sciences Initiates REPEL-CV Clinical
>Trials - Adhesion barrier could become routine part of heart surgery.
>
>http://www.allencaron.com/clients/lifemed/releases/12199.htm
>
>3.) * PRESS RELEASES - for Life Medical Sciences - click: Press Releases
>
>http://www.lifemed.com/
>
>~~~~~~~~~~~~~~~~~~~~~
>
>** ML LABORATORIES **
>
>1.) * ML Laboratories - ADEPT
>
>http://www.mllabs.co.uk/pages/report16.htm
>
>2.) * 11-01-1999 -- ML's Adept approved for post-operative adhesions
>reduction -- click title for more information and scroll down.
>
>http://www.mllabs.co.uk/pages/prmain24.htm
>
>3.) * 11-18-1999 -- ML progresses towards US approval of Adept. Interim
>results of USA trials filed with FDA -- scroll down.
>
>http://www.mllabs.co.uk/pages/prmain26.html
>
>4.) * PRESS RELEASES - for ML Laboratories
>
>http://www.mllabs.co.uk/pages/pr.htm
>
><

--
pLEASE LET ME KNOW NAMES & ADDRESSES OF
DOCTORS YOU KNOW WHO PERFORM THE BARRIER
TYPE ADHESION REMOVAL SURGERY.  I LIVE
IN SOUTH CAROLINA.  MANY THANKS.

Enter keywords:
Returns per screen: Require all keywords: